Skip to main content
Izotropic Corporation logo

Izotropic Corporation — Investor Relations & Filings

Ticker · IZO ISIN · CA46604F1099 LEI · 529900IZ5PIVM7X6S027 CSE Manufacturing
Open in API
Filings indexed 368 across all filing types
Latest filing 2025-01-09 Regulatory Filings
Country CA Canada
Listing CSE IZO

About Izotropic Corporation

https://izocorp.com/

Izotropic Corporation develops and commercializes diagnostic medical devices, specializing in advanced breast cancer detection technology. Its flagship product is IzoView, a dedicated Breast CT imaging platform. IzoView utilizes high-resolution, true 3D imaging without requiring breast compression, offering superior spatial resolution compared to traditional modalities. The system is purpose-built to improve diagnostic accuracy and patient comfort, particularly targeting the 50% of women with dense breast tissue where conventional screening tools are often inadequate. Izotropic is currently advancing IzoView through pivotal clinical studies toward product launch and commercialization.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings Classification · 85% confidence The document is a corporate press release dated January 9, 2025 announcing that Izotropic has filed a pre-submission with the U.S. FDA for clinical study design feedback on its IzoView Breast CT Imaging System. It is not an earnings announcement, financial report, proxy statement, or shareholder vote result, nor is it a detailed annual or interim report. Instead, it is a general regulatory update about a U.S. FDA filing. Accordingly, this fits the “Regulatory Filings” category (RNS) as a general regulatory announcement.
2025-01-09 English
News release - English.pdf
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a corporate news release titled “IZOTROPIC ANNOUNCES AGM RESULTS,” summarizing and declaring the outcomes of shareholder votes at the Annual General Meeting. It provides the official voting results (director appointments, auditor appointment) from the company’s AGM. This matches the definition of Declaration of Voting Results & Voting Rights Announcements (Code: DVA).
2024-12-31 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings
2024-12-31 English
Interim MD&A - English.pdf
Regulatory Filings
2024-12-31 English
Interim financial statements/report – English.pdf
Regulatory Filings
2024-12-31 English
News release - English.pdf
Report Publication Announcement Classification · 91% confidence The document is a news release advising shareholders that the AGM notice, information circular, proxy form, and other meeting materials are now posted on SEDAR+ and the company’s website. It does not include the full annual report or proxy statement itself, but simply announces the publication and availability of those documents. The text is under 5,000 characters and clearly states that the materials "have been posted" and provides links, fitting the “Report Publication Announcement” definition rather than containing the full report or proxy materials. Thus, it should be classified as an RPA.
2024-12-05 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.